Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of F11 protein | affects expression | 20106945
|
D003913 |
Dextroamphetamine |
Dextroamphetamine results in increased expression of F11 mRNA | increases expression | 12558987
|
D002122 |
Calcium Chloride |
[F11 protein co-treated with Calcium Chloride] results in increased activity of F9 protein | affects cotreatment|increases activity | 6604052
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of F11 mRNA | decreases expression | 20106945
|
D004958 |
Estradiol |
Estradiol results in decreased expression of F11 mRNA | decreases expression | 20106945
|
D007460 |
Iodoacetamide |
Iodoacetamide results in increased cleavage of F11 protein | increases cleavage | 6604052
|
D007616 |
Kaolin |
Kaolin results in decreased activity of F11 protein | decreases activity | 6604052
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in decreased expression of F11 mRNA | decreases expression | 18467677
|
C023036 |
perfluorooctanoic acid |
PPARA protein promotes the reaction [perfluorooctanoic acid results in decreased expression of F11 mRNA] | decreases expression|increases reaction | 18467677
|
D010634 |
Phenobarbital |
Phenobarbital affects the expression of F11 mRNA | affects expression | 19136022
|
C006253 |
pirinixic acid |
pirinixic acid affects the expression of F11 mRNA | affects expression | 19136022
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of F11 mRNA | affects binding|decreases expression|increases activity | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of F11 mRNA | decreases expression | 18467677 17950772 18445702
|
C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in decreased expression of F11 mRNA] | decreases expression|increases reaction | 18467677 17950772
|
D020849 |
Raloxifene |
Raloxifene results in increased activity of F11 protein | increases activity | 16359964
|
C040190 |
S 2366 |
F11 protein alternative form affects the metabolism of S 2366 | affects metabolic processing | 6604052
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of F11 mRNA | increases expression | 11489354 20106945
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
8.69 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.69 | 15322242 14514962 11752688 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.20 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.11 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
18.00 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
18.00 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
18.00 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.69 | 17308373 17451421 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.55 | 15800139 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.02 | 11748828 |
MESH:D001169 |
Arthritis, Experimental |
|
Kaolin |
6.03 | 17392412 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.04 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.04 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.92 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.81 | 15746008 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.58 | 16580743 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.87 | 17289903 17261762 12948864 19861407 17018787 14630087 18497071 16675129 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
1.87 | 15775269 17952589 15758505 17242785 17440819 17261762 17893378 17049068 16912660 16837676 15572757 17595753 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.87 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.58 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.86 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
4.67 | 12907637 21507988 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
4.67 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
4.67 | 17173139 1701930 20007298 20935162 6705139 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
4.15 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.41 | 18850075 18670907 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.50 | 15775269 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.76 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
6.76 | 18566989 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.36 | 4080065 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.23 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.96 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.96 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.13 | 15340226 8697196 12621046 16354765 15668235 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.72 | 15800139 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.13 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 20055451 10048152 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.23 | 17474826 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.46 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.68 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
9.25 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
9.25 | 15920148 17451421 17308373 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.55 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.82 | 11462148 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
4.09 | 1851702 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
17.16 | 17259670 12083418 |
MESH:D004487 |
Edema |
|
pirinixic acid |
17.16 | 12083418 |
MESH:D004487 |
Edema |
|
Raloxifene |
17.16 | 15860553 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
17.16 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.04 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
4.09 | 15845917 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
3.03 | 11473722 19148513 18566989 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.10 | 10568697 9294722 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
4.21 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
4.00 | 3922381 11558140 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.93 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.61 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.36 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
4.14 | 3659116 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.07 | 11564622 |
MESH:D005173 |
Factor XI Deficiency |
marker/mechanism |
|
| |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
13.59 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
13.59 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
13.59 | 17473493 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.56 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.83 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.83 | 20067830 |
MESH:D005756 |
Gastritis |
|
Iodoacetamide |
6.42 | 15046732 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.34 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.73 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.37 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.59 | 11110106 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.58 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.54 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.42 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
21.62 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
21.62 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
21.62 | 18467677 19176532 19772884 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
21.62 | 12621046 16120746 15340226 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.17 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.89 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.18 | 8697196 16959395 15340226 18606429 16354765 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
3.92 | 12083418 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.26 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.75 | 10903974 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
8.75 | 17577099 15787275 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.75 | 18850075 18670907 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
5.28 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.28 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.37 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.37 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.42 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.58 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.08 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
6.08 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.50 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
7.50 | 15610895 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.58 | 16973256 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
5.35 | 8812269 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
2.94 | 21047994 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.42 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.42 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.42 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
2.19 | 19363144 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
14.56 | 18177683 2125692 15890375 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
14.56 | 18709148 14757943 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
14.56 | 19812893 8742319 15975961 19482888 19073162 21047994 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
14.56 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
14.56 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
10.11 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
10.11 | 6150874 1399818 2563599 17172636 18308698 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
10.11 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
2.32 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.32 | 19555203 11884234 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
2.61 | 11807958 11408345 17203775 16891317 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.62 | 19453300 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.92 | 16801185 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.69 | 15863610 |
MESH:D009041 |
Motion Sickness |
|
Dextroamphetamine |
5.65 | 1613127 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.49 | 16497877 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.61 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.17 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.08 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
8.46 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
8.46 | 16411023 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.59 | 17484760 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.69 | 16343187 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
1.98 | 17405874 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.85 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.58 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.36 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.78 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.78 | 14600291 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
5.06 | 9802331 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.83 | 20558911 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.48 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.44 | 17882678 15775268 19059307 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.31 | 15758505 15579764 17893378 17823083 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.24 | 19401270 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
2.52 | 16965848 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.38 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.65 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
9.21 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
9.21 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
10.07 | 17132714 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
10.07 | 11896295 11118676 11399792 11222880 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.97 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.32 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
3.32 | 16536755 15731164 16220300 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.63 | 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.25 | 16882103 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.69 | 15770314 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.42 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.93 | 18990726 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
2.74 | 11442880 3137016 16876388 4039156 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.94 | 6407741 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.08 | 16192470 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.89 | 16837676 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.04 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
3.11 | 1399818 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
14.17 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
14.17 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
2.84 | 17572228 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.12 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.73 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.34 | 16837676 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.69 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.38 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.58 | 17120751 |